7,654.25

+40.25

+0.53%

52,132.00

+214.00

+0.41%

28,815.50

+281.50

+0.99%

Russell 2000 Futures

2,839.30

+18.00

+0.64%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,924.60

+25.70

+0.66%

78,298.68

+533.69

+0.69%

Crude Oil Dec 26

100.27

-3.85

-3.70%

US Private Equity

10,850.63

-82.20

-0.75%

NasdaqCM - Delayed Quote USD

Bone Biologics Corporation (BBLGW)

7.70 +7.70 (0.00%)

At close: October 9 at 1:32:03 PM EDT

Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook

GlobeNewswire 9mo ago

BBLGW
0.00%
BBLG
Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months

GlobeNewswire 10mo ago

BBLG

BBLGW
0.00%
BBLG Earnings Illustrate Opportunity

Zacks Small Cap Research 5d ago

BBLG
Bone Biologics Expands Trial Sites

GlobeNewswire 1mo ago

BBLG
Bone Biologics Extends rhNELL-1 Validated Shelf Life to 32 Months as NB1 Study Advances

InvestorsHub 2mo ago

BBLG
Bone Biologics Achieves 32-Month Validated Shelf Life for rhNELL-1

GlobeNewswire 2mo ago

BBLG
Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities

GlobeNewswire 3mo ago

BBLGW
0.00%
BBLG

Mobilize your Website

View Site in Mobile | Classic

Share by: